Elon Musk’s Brain Implant Company Is Inching Toward Human Trials

Bloomberg2022-01-20

Neuralink has posted job listings for a clinical trial director and coordinator.Elon MuskPhotographer: Andrew Harrer/BloombergElon Musk’s brain implant company Neuralink is now hiring a clinical trial...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1108899147?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2022-01-20 22:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108899147","market":"us","top_or_hot":-1,"title":"Elon Musk’s Brain Implant Company Is Inching Toward Human Trials","media":"Bloomberg","content":"<div>\n<p>Neuralink has posted job listings for a clinical trial director and coordinator.Elon MuskPhotographer: Andrew Harrer/BloombergElon Musk’s brain implant company Neuralink is now hiring a clinical trial...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-01-20/elon-musk-s-brain-implant-company-is-inching-toward-human-trials\">网页链接</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk’s Brain Implant Company Is Inching Toward Human Trials</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk’s Brain Implant Company Is Inching Toward Human Trials\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-20 22:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-01-20/elon-musk-s-brain-implant-company-is-inching-toward-human-trials><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Neuralink has posted job listings for a clinical trial director and coordinator.Elon MuskPhotographer: Andrew Harrer/BloombergElon Musk’s brain implant company Neuralink is now hiring a clinical trial...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-01-20/elon-musk-s-brain-implant-company-is-inching-toward-human-trials\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TSLA","symbol_name":"特斯拉","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2022-01-20/elon-musk-s-brain-implant-company-is-inching-toward-human-trials","article_id":"1108899147","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108899147","pubTimestamp":1642690690,"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Neuralink has posted job listings for a clinical trial director and coordinator.Elon MuskPhotographe","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TSLA":"特斯拉"},"translate_title":"埃隆·马斯克的大脑植入公司正慢慢走向人体试验","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TSLA":0.9},"content_text":"Neuralink has posted job listings for a clinical trial director and coordinator.Elon MuskPhotographer: Andrew Harrer/BloombergElon Musk’s brain implant company Neuralink is now hiring a clinical trial director, an indication that the company’s longstanding goal of implanting chips in human brains is coming closer.The trial director position would oversee the startup’s long-promised human trials of its medical device, according to the listing. Neuralink’s brain implant — which Musk has said already allows monkeys to play video games with their thoughts alone — is intended to help treat a variety of neurological disorders, such as paralysis.The job description for the position, based in Fremont, California, promises that the applicant will “work closely with some of the most innovative doctors and top engineers” as well as with “Neuralink’s first Clinical Trial participants.” It also indicates that the job will mean leading and building “the team responsible for enabling Neuralink’s clinical research activities,” as well as adhering to regulations.Last month, Musk told the Wall Street Journal that Neuralink hoped to implant its device in human brains sometime in 2022. However, he has made similar predictions in the past that proved overly optimistic — including in 2019, when he said during apresentationthat the device would be in human skulls by the following year.The first in-human test that medical device makers must go through on the path to U.S. Food and Drug Administration approval is known as a feasibility test. The next, after a submission, review and approval process with the FDA based on the feasibility test, is a pivotal device test.It isn’t clear precisely where Neuralink is in the process. Representatives for Neuralink and the FDA didn’t respond to requests for comment. Generally, device makers hire trial directors early in their interaction with the FDA, to help design trials in a way that would maximize the chances of FDA approval. Neuralink doesn’t appear to have human trials posted on clinicaltrials.gov, but postings there can lag recruitment of the first patients.Last year, another company working on brain-machine interfaces, Synchron, said the FDA had approved its planned feasibility study. Synchron is currently in the recruiting stage, a spokeswoman said.Neuralink is also advertising for a Fremont-based clinical trial coordinator, as well as several other positions.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":15,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1108899147"}